Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Exicure
AddedFeb 19, 2024
UpdatedJun 18, 2026
Exicure

Exicure

Public

Chicago-based Exicure develops innovative immunomodulatory and gene silencing drugs, leveraging SNA technology for effective delivery and treatment of diseases.

HQ
Chicago, IL, US
Founded
2009
Overview
Compare
Fundraising
Employees

Exicure, based in Chicago, Illinois, develops innovative immunomodulatory and gene silencing drugs using their proprietary spherical nucleic acid (SNA™) technology. Their lead programs target a range of diseases, including inflammatory disorders and oncology, by overcoming challenges in the safe and effective delivery of nucleic acid therapeutics.

Exicure's SNA constructs have unlocked new potential in treating multiple organ systems, marking significant progress in the field of nucleic acid therapeutics. Their pioneering approach has positioned them as a leader in the biotech industry, making notable strides in addressing complex medical conditions.

Exicure - Similar Companies

Excepgen logo

Excepgen

excepgen.com

Excision BioTherapeutics logo

Excision BioTherapeutics

Exalys Therapeutics logo

Exalys Therapeutics

Xeris Biopharma Holdings logo

Xeris Biopharma Holdings

Exodos Life Sciences logo

Exodos Life Sciences

exodosls.com

Nurix logo

Nurix

nurixtx.com

ImmuneXcite logo

ImmuneXcite

Sanegene Bio logo

Sanegene Bio

sanegenebio.com

Xalud Therapeutics logo

Xalud Therapeutics

xaludthera.com

Solstice Biologics logo

Solstice Biologics

Sonexa Therapeutics logo

Sonexa Therapeutics

Durect logo

Durect

durect.com

Cygnal Therapeutics logo

Cygnal Therapeutics

eXIthera Pharmaceuticals logo

eXIthera Pharmaceuticals

exithera.com

Spyre Therapeutics logo

Spyre Therapeutics

aeglea.com

Exicure - Quick Facts

Who are Exicure's competitors?

Companies similar to Exicure include Excepgen, Excision BioTherapeutics, Exalys Therapeutics and Xeris Biopharma Holdings.

When was Exicure founded?

Exicure was founded in 2009.

Where is Exicure's headquarters located?

Exicure's headquarters is located in Chicago, IL, US.

When was Exicure's last funding round?

Exicure's most recent funding round was for $5.4M (USD) in September 2022.

How much has Exicure raised to-date?

As of Sep 26, 2022, Exicure has raised a total of $110.9M (USD).

How many employees does Exicure have?

Exicure has 19 employees as of Feb 6, 2024.

Exicure - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drugs
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • ein: 815333008
  • secCik: 0001698530
  • ticker: XCUR
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified